Oral PCSK9 Inhibitor, Role of Neurology Department Chairs, Anti-IgLON5 Disease

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the first oral PCSK9 inhibitor, the transforming role of the neurology department chair, and anti-IgLON5 disease.